Making Resident Well-Being a (Virtual) Reality

Sponsor
NYU Langone Health (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05395221
Collaborator
(none)
23
2
5

Study Details

Study Description

Brief Summary

This study is a prospective cross-over trial examining the effect of virtual reality assisted meditation on resident reported well-being using validated scoring systems. The primary objective of this study is to evaluate the effectiveness of virtual reality guided meditation as a mechanism to improve plastic surgery resident well-being. The secondary objective is to assess resident likeliness to continue mindful meditation following completion of the study.

Condition or Disease Intervention/Treatment Phase
  • Other: Guided Mediation Virtual Reality App
N/A

Detailed Description

All plastic surgery residents participating will spend three months with access to virtual reality assisted meditation and three months without access to this technology. Assessment scores will be taken before and after the first three month period, and then again following the second three month period.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
23 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Making Resident Well-Being a (Virtual) Reality
Anticipated Study Start Date :
Oct 1, 2022
Anticipated Primary Completion Date :
Mar 1, 2023
Anticipated Study Completion Date :
Mar 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Virtual Reality Assisted Meditation+ no intervention Group

The first cohort will undergo weekly virtual reality guided meditations across a three-month rotation using the Guided Mediation Virtual Reality App available on the Oculus Quest 2 Virtual Reality system (Oculus, Menlo Park, CA). After completion of the three-month time span, residents will receive no intervention during the second three-month study period. . A post-study survey will be completed to assess for various parameters including residents desire for continuation of virtual reality guided meditation following completion of the survey, subjective value of virtual reality as a tool for burnout, and likeliness to recommend virtual reality guided meditation to a colleague.

Other: Guided Mediation Virtual Reality App
Guided Meditation Virtual Reality App uses over 40 lush environments with 30 hours of guided meditations on Anxiety, Depression, Maternity, Resilience, Sleep, or Zen and 200 relaxing audio tracks using Virtual reality.

Experimental: No intervention + Virtual Reality Assisted Meditation group

The second cohort will receive no intervention during the three-month block. After completion of the three-month time span, residents will take a follow-up MBI and then will cross over to the opposite group. After completion of the second three-month study period, an additional MBI will be completed by the residents.. A post-study survey will be completed to assess for various parameters including residents desire for continuation of virtual reality guided meditation following completion of the survey, subjective value of virtual reality as a tool for burnout, and likeliness to recommend virtual reality guided meditation to a colleague.

Other: Guided Mediation Virtual Reality App
Guided Meditation Virtual Reality App uses over 40 lush environments with 30 hours of guided meditations on Anxiety, Depression, Maternity, Resilience, Sleep, or Zen and 200 relaxing audio tracks using Virtual reality.

Outcome Measures

Primary Outcome Measures

  1. Change in Emotional Exhaustion as measured by Maslach Burnout Inventory (MBI) [Baseline, 3 month visit, 6 month visit]

    Emotional exhaustion as measured by Maslach Burnout Inventory (MBI) before and after virtual reality guided meditations. All MBI items are scored using a 7 level frequency ratings from "never" to "daily." The MBI has three component scales: emotional exhaustion (9 items), depersonalization (5 items) and personal achievement (8 items). Each scale measures its own unique dimension of burnout. Higher scores in emotional exhaustion contribute to higher levels of burnout.

  2. Change in Depersonalization as measured by Maslach Burnout Inventory (MBI) [Baseline, 3 month visit, 6 month visit]

    Depersonalization as measured by Maslach Burnout Inventory (MBI) before and after virtual reality guided meditations. All MBI items are scored using a 7 level frequency ratings from "never" to "daily." The MBI has three component scales: emotional exhaustion (9 items), depersonalization (5 items) and personal achievement (8 items). Each scale measures its own unique dimension of burnout. Higher scores in depersonalization contribute to higher levels of burnout.

  3. Change in personal accomplishment as measured by Maslach Burnout Inventory (MBI) [Baseline, 3 month visit, 6 month visit]

    Personal accomplishment as measured by Maslach Burnout Inventory (MBI) before and after virtual reality guided meditations. All MBI items are scored using a 7 level frequency ratings from "never" to "daily." The MBI has three component scales: emotional exhaustion (9 items), depersonalization (5 items) and personal achievement (8 items). Each scale measures its own unique dimension of burnout. Lower scores in personal accomplishment are suggestive of a more severe degree of burnout.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 99 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Current resident of NYU Langone Plastic Surgery (Academic Year 2022-2023)

  • Consent to participation in the study

Exclusion Criteria:
  • Any plastic surgery resident involved in conducting the study

  • Any non-plastic surgery resident during the academic year 2022-2023

  • Any plastic surgery resident choosing not to participate in the study

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • NYU Langone Health

Investigators

  • Principal Investigator: Vishal Thanik, NYU Langone Health

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
NYU Langone Health
ClinicalTrials.gov Identifier:
NCT05395221
Other Study ID Numbers:
  • 21-01719
First Posted:
May 27, 2022
Last Update Posted:
Aug 15, 2022
Last Verified:
Aug 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Aug 15, 2022